To see if Nanocrystalline silver dressings are better than conventional dressings in treating diabetic foot ulcer patients
Phase 2
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2024/04/065881
- Lead Sponsor
- DrRamkamal Balachandran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
grade 1 and 2 wagners classification
ulcer duration > 3 weeks
able to understand procedure and provide consent
Exclusion Criteria
1.patients with cardiac disease, HIV, Hepatitis, critically ill patients
2.pregnancy
3.chronic venous/arterial insufficiency ulcer
4.malignant ulcer
5.Hb <7g/dl
6.Known or suspected osteomyelitis
7.ulcer <2cm size
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in wound sizeTimepoint: Day-0, 1 week and 2 weeks
- Secondary Outcome Measures
Name Time Method Improvement in granulation formationTimepoint: Day-0, 1 week & 2 weeks